Lack of MHC class I surface expression on neoplastic cells and poor activation of the secretory pathway of cytotoxic cells in oral squamous cell carcinomas
- PMID: 10555762
- PMCID: PMC2374311
- DOI: 10.1038/sj.bjc.6690780
Lack of MHC class I surface expression on neoplastic cells and poor activation of the secretory pathway of cytotoxic cells in oral squamous cell carcinomas
Abstract
Cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells use the secretory pathway of perforin/granzymes to kill their target cells. In contrast to NK cells, CTL responses are MHC class I restricted. In this study we analysed the relative activation of CTL and NK cells in relation with MHC class I expression on oral squamous cell carcinomas (OSCCs). MHC class I expression was investigated in 47 OSCCs by immunohistochemistry using HCA2, HC10 and beta2-m antibodies. The presence of CTLs, NK cells, and its activation, was investigated in 21 of these OSCCs using respectively, CD8, CD57 and GrB7 antibodies. The Q-Prodit measuring system was used for quantification of cytotoxic cells. All OSCCs showed weak or absent staining of beta2-m on the cell surface. The absence of beta2-m was significantly associated with absent expression of MHC class I heavy chain as detected by HC10 antibody (P = 0.004). In tumour infiltrates CTLs always outnumbered NK cells, as reflected by the ratio CD57/CD8 being always inferior to one (mean: 0.19; SD: 0.15). The proportion of activated cytotoxic cells as detected by granzyme B expression was generally low (mean: 8.6%; SD 8.9). A clear correlation between MHC class I expression and the relative proportion of NK cells/CTLs was not found. This study shows that the majority of OSCCs show weak or absent expression of MHC class I molecules on the cell surface, possibly due to alterations in the normal beta2-m pathway. The low proportion of granzyme B-positive CTLs/NK cells indicates that the secretory pathway of cytotoxicity is poor in these patients. The lack of correlation between MHC class I expression and CTL/NK cell activation as detected by granzyme-B expression suggests that, next to poor antigen presentation, also local factors seem to determine the final outcome of the cytotoxic immune response.
Similar articles
-
Assessment of cytotoxic T-lymphocyte phenotype using the specific markers granzyme B and TIA-1 in cervical neoplastic lesions.Br J Cancer. 1997;76(10):1353-60. doi: 10.1038/bjc.1997.560. Br J Cancer. 1997. PMID: 9374383 Free PMC article.
-
Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells.Blood. 2004 Nov 1;104(9):2840-8. doi: 10.1182/blood-2004-03-0859. Epub 2004 Jul 6. Blood. 2004. PMID: 15238416
-
Serglycin determines secretory granule repertoire and regulates natural killer cell and cytotoxic T lymphocyte cytotoxicity.FEBS J. 2016 Mar;283(5):947-61. doi: 10.1111/febs.13649. Epub 2016 Jan 22. FEBS J. 2016. PMID: 26756195
-
Cellular mechanisms of lymphocyte-mediated lysis of tumor cells.Ann Ist Super Sanita. 1990;26(3-4):369-84. Ann Ist Super Sanita. 1990. PMID: 2151107 Review.
-
Teleost T and NK cell immunity.Fish Shellfish Immunol. 2013 Aug;35(2):197-206. doi: 10.1016/j.fsi.2013.04.018. Epub 2013 May 7. Fish Shellfish Immunol. 2013. PMID: 23664867 Review.
Cited by
-
Phenotype of p53 wild-type epitope-specific T cells in the circulation of patients with head and neck cancer.Sci Rep. 2018 Jul 16;8(1):10716. doi: 10.1038/s41598-018-29067-5. Sci Rep. 2018. PMID: 30013227 Free PMC article.
-
Recent Progress towards Novel EV71 Anti-Therapeutics and Vaccines.Viruses. 2015 Dec 8;7(12):6441-57. doi: 10.3390/v7122949. Viruses. 2015. PMID: 26670245 Free PMC article. Review.
-
A CSF-1R-blocking antibody/IL-10 fusion protein increases anti-tumor immunity by effectuating tumor-resident CD8+ T cells.Cell Rep Med. 2023 Aug 15;4(8):101154. doi: 10.1016/j.xcrm.2023.101154. Cell Rep Med. 2023. PMID: 37586318 Free PMC article.
-
Combination of laser microdissection, 2D-DIGE and MALDI-TOF MS to identify protein biomarkers to predict colorectal cancer spread.Clin Proteomics. 2019 Jan 22;16:3. doi: 10.1186/s12014-019-9223-7. eCollection 2019. Clin Proteomics. 2019. PMID: 30679934 Free PMC article.
-
T cell-tumor interaction directs the development of immunotherapies in head and neck cancer.Clin Dev Immunol. 2010;2010:236378. doi: 10.1155/2010/236378. Epub 2010 Dec 27. Clin Dev Immunol. 2010. PMID: 21234340 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous